FDA Investigator Xiaoping Guan
Xiaoping Guan has inspections in 9 countries as of 23 Oct 2023. Xiaoping Guan has collaborated with a combined 2532 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
18
Last Inspection Date:
23 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Italy,
France,
Germany,
Belgium,
United States of America,
United Kingdom of Great Britain and Northern Ireland,
China,
Austria,
Switzerland
Co-Investigator(s):
Addam S Reynolds,
Ademola O Daramola,
Aditi S Thakur,
Alice S Tsao,
Alicia M Mozzachio,
Amir Alavi,
Amy M Cramer,
Anastasia M Shields,
Andrea A Branche,
Anjali Shukla, PhD,
Ann M Stewart,
Aziz A Mamur,
Azza Talaat,
Barbara Jwilimczyk Macri,
Byungja E Marciante,
Camerson E Moore,
Carla J Lundi,
Caryn M Mcnab,
Charisse K Green,
Christine W Twohy,
Christopher S Keating,
Christopher T Middendorf,
Cynthia Jim, CSO,
Darren S Brown,
David Acevedo,
David K Lau,
David R Delucia,
Deborah Schmiel, PhD,
Demitria J Xiradakis,
Denise M Digiulio,
Dhaval H Patel,
Dr. Gang Wang, PhD,
Eric J Cunningham,
Erik W Koester,
Erika V Butler,
Evan Tong,
Felix Maldonado,
Francis A Guidry,
Frank J Marciniak,
German Rivera,
Gilbert T Salud,
Heika R Tait,
Iram R Hassan, PhD,
Ivis Lnegron Torres,
Jacqueline Mdiaz Albertini,
James A Liubicich,
James K Rice,
James L Dunnie, Jr,
Jean M Kelahan,
Jennifer J Stone,
Jennifer M Gogley,
Joey V Quitania,
Jose Alopez Rubet,
Jose M Cayuela,
Joy P Matthias,
Justin A Boyd,
Kathy E Craven,
Kathy E Noe,
Kelly I Anderson,
Kevin A Gonzalez,
Kevin D Kallander,
Kevin P Foley,
Kinh Q Mac,
Laura Fontan, MS,
Lawrence W Farina,
Lewis K Antwi,
Linda F Murphy,
Linda Thai,
Luella J Rossi,
Marcus F Yambot,
Margaret M Annes,
Maria Joselopez Barragan, PhD,
Marie F Morin,
Marijo B Kambere, PhD,
Marion Michaelis,
Marjorie A Shapiro, PhD,
Maryam Tabatabaie,
Matthew A Spataro,
Maya M Davis,
Meyer J Slobotsky,
Michael E Maselli,
Michael J Kuchta,
Michael Levin,
Michael Shanks, MS,
Mihaly S Ligmond,
Mra B Kamberem,
Mra M Barbosar,
Mra Mcculloughj,
Nicholas A Vicland,
Nicholas A Violand,
Noreen Muniz,
Omotunde O Osunsanmi,
Patricia Fhughes Troost,
Patrick C Klotzbuecher,
Paul A Bonneau,
Paul L Bellamy,
Paul L Figarole, Jr,
Paul Mouris,
Paula A Trost,
Perry T Nichols,
Peter Adams, PhD,
Prabhu P Raju,
Rachel C Harrington,
Ramon E Martinez,
Raymond T Oji,
Regina T Brown,
Reyes Candau Chacon, PhD,
Richard J Friedman,
Richard L Friedman,
Robert C Coleman,
Robert C Steyert,
Robert M Barbosa,
Rochelle K Kimmel,
Roy R Rinc,
Russell J Glapion,
Samina S Khan,
Sangeeta M Khurana, PhD,
Sarah Forney,
Satheesh Thomas,
Scott R Nichols, PhD,
Scott T Ballard,
Shari L Kahn,
Shirley J Berryman,
Simone E Pitts,
Stephanie A Slater, MS,
Stephen D Brown,
Steven M Weinman,
Steven P Donald,
Susan M Jackson,
Susan P Bruederle,
Syeda N Mahazabin,
Thuy T Nguyen, LCDR,
Tiara Nbrown Crosen,
Uduak M Inokon,
Vanessa M Williams,
Vincent M Williams,
Wayne E Seifert,
William Hallett, PhD,
Xiaokuang Lai, PhD,
Yumi J Hiramine,
Zhong Li, PhD
Xiaoping Guan's Documents
Publish Date | Document Type | Title |
---|---|---|
May, 2015 | FDA 483 | Patheon Italia S.p.A - Form 483, 2015-05-19 |
May, 2015 | FDA 483 | Corden Pharma Latina S.p.A. - Form 483, 2015-05-29 |
September, 2015 | FDA 483 | Excelsior Medical LLC - Form 483, 2015-09-29 |
September, 2017 | EIR | Bioreliance Ltd. - EIR, 2017-09-22 |
July, 2016 | FDA 483 | Sandoz GmbH - Form 483, 2016-07-05 |
August, 2014 | FDA 483 | Excelsior Medical LLC - Form 483, 2014-08-21 |
December, 2013 | EIR | Epic Pharma, LLC - EIR, 2013-12-23 |
July, 2016 | FDA 483 | CORDEN PHARMA SPA - Form 483, 2016-07-15 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more